Attachment
Gates Package, p.930 · gates:exh:00340
Page text: p.930 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
the pandemic hit. In fact, the lack of coordination between the partially staffed groups became
part of the problem.
What we need at both the global and country levels is a well-funded organization with
enough full-time experts in all the necessary areas, the credibility and authority that come with
being a public institution, and a clear remit to work on nothing but preventing pandemics.
I call the global team the GERM--Global Epidemic Response and Mobilization--team,
and their job should be to wake up every day asking themselves the same questions: "Is the
world ready for the next outbreak? What can we do to be better prepared?" They should be fully
paid, regularly drilled, and prepared to mount a coordinated response to the next threat of a
pandemic.
My back-of-the-napkin estimate is that GERM would need 2,000 to 3,000 full-time
employees. Their skills should run the gamut: epidemiology, genetics, drug and vaccine
development, data systems, diplomacy, rapid response, logistics, computer modeling, and
communications. GERM should be managed by the World Health Organization, the only group
that could give it global credibility. It should have a diverse workforce, with a decentralized staff
working in places around the world but paid out of a central fund. Most of GERM's staff would
be based in the countries where outbreaks are most likely to happen, though some would sit in
the WHO's regional offices and at its headquarters in Geneva.
When there's a potential pandemic looming, the world needs expert analysis of early data
points that can confirm the threat. GERM's data scientists would build a system for monitoring
reports of clusters of suspicious cases. Epidemiologists would monitor reports from national
governments and work with the WHO to identify anything that looks like an outbreak. Productdevelopment experts would advise governments and companies on the highest-priority drugs and